THE EFFECT OF INTERFERON AND RIBAVIRIN TREATMENT ON HEARING LEVELS IN PATIENTS WITH CHRONIC HEPATITIS C


ŞENOL A., Aksakal G., AKIN M., Yariktas M., GÖREN İ., Isler M.

NOBEL MEDICUS, vol.12, no.1, pp.35-38, 2016 (Peer-Reviewed Journal) identifier identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 1
  • Publication Date: 2016
  • Journal Name: NOBEL MEDICUS
  • Journal Indexes: Emerging Sources Citation Index, Scopus
  • Page Numbers: pp.35-38

Abstract

Objective: Combination of interferon (IFN) alfa and ribavirin therapy is widely used for the treatment of chronic hepatitis C. Various side effects such as flu like symptoms, depression, autoimmune tiroiditis, vertigo, skin rashs, acute myocarditis and bone marrow supression may be seen with this therapy, however, the effect on hearing levels is not clearly evaluated. In this study, we investigated the effect of IFN alfa-2b and ribavirin combination therapy on the hearing levels in patients with chronic hepatitis C.